Last reviewed · How we verify

NCT03380013

OMT to Improve Feeding After Hypothermia

Completed NA Last updated 31 May 2019
What this trial tests

NA trial testing Osteopathic Manipulative Treatment (OMT) in Neonatal Encephalopathy in 12 participants. Completed in 30 April 2019.

Timeline
24 October 2017
Primary endpoint
30 April 2018
30 April 2019

Quick facts

Lead sponsorMaineHealth
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date24 October 2017
Primary completion30 April 2018
Estimated completion30 April 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

MaineHealth — full company profile →

Who can join

37 Weeks and older, any sex, with Neonatal Encephalopathy or Feeding; Difficult, Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to determine if infants with neonatal encephalopathy will achieve full oral feeds faster after therapeutic hypothermia has completed if they are treated with osteopathic manipulative treatment. The treated infants will be compared to matched historical controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Osteopathic Manipulative Treatment (OMT)

Trials testing the same drug.

Other recruiting trials for Neonatal Encephalopathy

Currently open trials in the same condition.

Other MaineHealth trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03380013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing